The Canadian scientists proved that the successful result of tobacco addiction treatment depends on genetic traits of each individual. Consequently, the antismoking medication doesn’t always have the desired effect.
This discovery was made in the Centre for Addiction and Mental Health in Canada. The research findings were published in Biological Psychiatry.
It was found out that the enzymes that take part in the antismoking drugs assimilation by human organism differ at the genetic level of various ethnic groups very much, that influence the efficiency of that pernicious addiction control.
The analysis of these findings demonstrated that not only difficulties of the nicotine withdrawal syndrome flowing but also the efficiency of drugs applied for its treatment depends on genetic factor, i.e. the CYP'B6 gene form.
The scientists found out that tobacco users with low-active gene form (that is carried by 25% of people) cannot quit their pernicious habit incomparably longer than smokers with ordinary CYP'B6 form.
This discovery will help scientists in establishing various treatment strategies, specific for each patient.
Subscribe to:
Post Comments (Atom)
2 comments:
I still believe it can be bent with enough willpower and discipline. :)
Well, you cant cry for the moon
Post a Comment